The Indomethacin Trial: Supportive Evidence
At a Glance
For hemicrania continua, a supervised indomethacin trial is supportive when it completely removes both the constant headache and severe flares, often within 8–24 hours, but imaging is still needed because other causes can respond too.
The indomethacin trial is more than just a treatment—it is a critical diagnostic tool. Because Hemicrania Continua (HC) is defined by its “absolute” response to this specific medication, the trial serves as strong supportive evidence for the diagnosis [1][2]. If your doctor has suspected HC based on your symptoms, this supervised trial helps see if your headache fits the clinical profile.
What is an “Absolute Response”?
In most medical conditions, a medication is considered successful if it reduces your pain by half. For Hemicrania Continua, the bar is much higher. An absolute response means the complete disappearance of all headache symptoms [1].
This includes:
- The total elimination of the 24/7 background ache [3].
- The total elimination of the severe spikes and their accompanying physical symptoms (like eye watering or nasal congestion) [3][4].
If the medication only makes the pain “better” but does not remove it entirely, your prescriber will decide if the dose or duration was adequate. A partial response does not confirm HC. Never self-test or increase your dose on your own. If you only have partial relief, wait for your doctor’s advice [5][6].
The Timeline for Relief
One of the most striking features of the indomethacin trial is how quickly it can work. Many patients experience a dramatic improvement within 8 to 24 hours of reaching an effective dose [7][8].
However, every person’s body processes medication differently. While a rapid response is common, some people may require a longer trial—sometimes up to two weeks—at a therapeutic dose before the pain fully clears [9][7]. Your doctor will likely start you at a lower dose and gradually increase it (a process called titration) until the pain is controlled or side effects prevent further increases [5].
Why Indomethacin?
You may wonder why your doctor is prescribing indomethacin specifically, rather than other common pain relievers like ibuprofen or naproxen. While all of these belong to a class of drugs called NSAIDs (non-steroidal anti-inflammatory drugs), indomethacin appears to have a unique effect on HC [10].
Scientists are still researching exactly why this is. Current research hypotheses suggest that indomethacin may uniquely inhibit nitric-oxide signaling, a chemical messenger involved in trigeminal nerve pain, or that it has specific effects on cerebral blood vessels [11][12]. However, the exact clinically relevant mechanism remains unproven.
⚠️ Important Safety Warning: Emergency Side Effects
Indomethacin is a potent medication and can cause serious adverse effects. Stop the medication and seek emergency medical care immediately if you experience:
- Vomiting blood or material that looks like coffee grounds.
- Black, tarry, or bloody stools.
- Severe chest pain or shortness of breath.
- Markedly reduced urination or severe ankle swelling.
- Severe allergic symptoms (hives, facial swelling, severe difficulty breathing).
- Severe confusion or sudden weakness [13][14].
Important Safety Considerations
Because indomethacin is a very potent medication, it must be used with care. It is known to be particularly “tough” on the digestive system. To protect your stomach, doctors often prescribe a gastroprotective medication (such as a proton pump inhibitor) to take alongside it based on an individualized risk assessment [15][16].
Common side effects to monitor during your trial include:
- Stomach pain or heartburn [15].
- Dizziness or a “spaced-out” feeling [13].
- Changes in blood pressure [15].
A Response is Not the Final Step
It is vital to understand that a successful indomethacin trial is a major diagnostic criterion, but it is not unique to HC and does not exclude a secondary cause. While most cases are “primary” (meaning the headache is the only problem), some serious underlying issues—such as vascular problems or small lesions—can also respond perfectly to indomethacin [6][9].
For this reason, even if the medication works perfectly, your care team will still need to perform imaging (like an MRI) to ensure there are no secondary causes for the pain [9][17]. The successful trial provides strong supportive evidence, but evaluating for secondary causes remains essential.
Common questions in this guide
What counts as a complete response to indomethacin for hemicrania continua?
How quickly should indomethacin work during an HC trial?
Does partial relief mean I have hemicrania continua?
Why is an MRI still needed if indomethacin completely stops my pain?
Which indomethacin side effects need emergency care?
Should I take a stomach-protecting medicine with indomethacin?
What health history should I tell my doctor before an indomethacin trial?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What exact dose and schedule should I follow for this trial, and how long should I wait before deciding if it's working?
- 2.If I only feel 'mostly' better but still have some pain, does that count as a successful trial?
- 3.Since indomethacin can be hard on the stomach, should I take a protective medication like a proton pump inhibitor during the trial?
- 4.If the trial is successful, what are our next steps for imaging my brain to rule out other causes?
- 5.What symptoms or side effects should I watch for that would mean I need to stop the medication immediately?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Hemicrania Continua: An Update.
Al-Khazali HM, Christensen RH, Lambru G, et al.
Current pain and headache reports 2023; (27(10)):543-550 doi:10.1007/s11916-023-01156-9.
PMID: 37566220 - 2
Hemicrania Continua.
Prakash S, Adroja B
Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S23-S30 doi:10.4103/aian.AIAN_352_17.
PMID: 29720815 - 3
Hemicrania Continua: An Update.
Prakash S, Rawat KS
Neurology India 2021; (69(Supplement)):S160-S167 doi:10.4103/0028-3886.315976.
PMID: 34003161 - 4
Pharmacological Dissociation in Hemicrania Continua With Persistent Visual Aura Evolved From Episodic Migraine: A Case Report.
Grosberg BM, Friedman DI, Robbins MS, Verhaak AMS
The neurologist 2024; (29(6)):361-364 doi:10.1097/NRL.0000000000000583.
PMID: 39353868 - 5
Indomethacin Responsive Headaches: Exhaustive Systematic Review with Pooled Analysis and Critical Appraisal of 81 Published Clinical Studies.
Bordini EC, Bordini CA, Woldeamanuel YW, Rapoport AM
Headache 2016; (56(2)):422-35 doi:10.1111/head.12771.
PMID: 26853085 - 6
Indomethacin-Responsive Headache Disorders.
Goadsby PJ
Continuum (Minneapolis, Minn.) 2024; (30(2)):488-497 doi:10.1212/CON.0000000000001409.
PMID: 38568495 - 7
The Exacerbation of Hemicrania Continua Mimics Trigeminal Neuralgia.
Kato Y, Tamai Y, Hayashi T, et al.
Internal medicine (Tokyo, Japan) 2019; (58(5)):723-725 doi:10.2169/internalmedicine.1561-18.
PMID: 30333409 - 8
Hemicrania Continua Associated with Classic Scintillating Scotoma.
Auffenberg E, Bender F, Freilinger T
Case reports in neurology 2018; (10(1)):83-87 doi:10.1159/000487881.
PMID: 29681827 - 9
The critical role of neuroimaging in hemicrania continua: A systematic review and case series.
Yildiz Goksel H, Bilgin S, Digre K, et al.
Headache 2024; (64(6)):674-684 doi:10.1111/head.14728.
PMID: 38780233 - 10
Indomethacin-responsive headaches-A narrative review.
Villar-Martínez MD, Moreno-Ajona D, Chan C, Goadsby PJ
Headache 2021; (61(5)):700-714 doi:10.1111/head.14111.
PMID: 34105154 - 11
Differential actions of indomethacin: clinical relevance in headache.
Summ O, Andreou AP, Akerman S, et al.
Pain 2021; (162(2)):591-599 doi:10.1097/j.pain.0000000000002032.
PMID: 32796319 - 12
The Pharmacology of Indomethacin.
Lucas S
Headache 2016; (56(2)):436-46 doi:10.1111/head.12769.
PMID: 26865183 - 13
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?
Osiowski A, Stolarz K, Taterra D
Current opinion in neurology 2025; (38(3)):254-261 doi:10.1097/WCO.0000000000001347.
PMID: 39911098 - 14
Hemicrania continua may respond to repetitive sphenopalatine ganglion block: A case report.
Androulakis XM, Krebs KA, Ashkenazi A
Headache 2016; (56(3)):573-9 doi:10.1111/head.12783.
PMID: 26926875 - 15
Hemicrania Continua: Beneficial Effect of Non-Invasive Vagus Nerve Stimulation in a Patient With a Contraindication for Indomethacin.
Eren O, Straube A, Schöberl F, Schankin C
Headache 2017; (57(2)):298-301 doi:10.1111/head.12977.
PMID: 27861830 - 16
The spectrum of indomethacin-responsive headaches in children and adolescents.
Myers KA, Barmherzig R, Raj NR, et al.
Cephalalgia : an international journal of headache 2022; (42(8)):793-797 doi:10.1177/03331024221076483.
PMID: 35302385 - 17
Hemicrania continua in carotid artery dissection - symptomatic cases or linked pathophysiology?
Brilla R, Pawlowski M, Evers S
Cephalalgia : an international journal of headache 2018; (38(2)):402-405 doi:10.1177/0333102416686346.
PMID: 28056533
This page explains how a supervised indomethacin trial may support evaluation of hemicrania continua for informational purposes only and does not constitute medical advice. Do not start, stop, or change indomethacin without your prescriber’s guidance, and seek emergency care for serious symptoms.
Get notified when new evidence is published on Hemicrania continua.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.